Spero Therapeutics, Inc. Stock Börse Stuttgart
Stocks
2HA
US84833T1034
Biotechnology & Medical Research
|
Delayed
Börse Stuttgart
03:02:03 10/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.001 EUR | -1.86% |
|
-0.78% | -46.48% |
| 08-13 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-13 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 69.3M 59.63M 56.15M 51.16M 95.72M 6.59B 96.1M 665M 257M 3.36B 260M 255M 10.64B | P/E 2024 |
-0.81x | P/E 2025 | 15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 69.3M 59.63M 56.15M 51.16M 95.72M 6.59B 96.1M 665M 257M 3.36B 260M 255M 10.64B | EV / Sales 2024 |
1,170,430x | EV / Sales 2025 | - |
| Free-Float |
77.39% | Yield 2024 * |
-
| Yield 2025 | - |
Börse StuttgartEUR
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SPRO | Delayed | |
Tradegate
| 2HA | Real-time | |
|
CBOE
| SPRO | Real-time | |
|
Boerse Muenchen
| 2HA | Real-time | |
|
Deutsche Boerse AG
| 2HA | Delayed | |
|
Börse Stuttgart
| 2HA | Delayed |
Last Transcript : Spero Therapeutics, Inc.
| 1 week | -0.78% | ||
| Current month | -2.30% | ||
| 1 month | -5.82% | ||
| 3 months | -56.96% | ||
| 6 months | -47.31% | ||
| Current year | -46.48% |
| 1 week | 1 |  | 1.05 |
| 1 month | 1 | | 1.1 |
| 3 years | 0.49 | | 2.6 |
| 5 years | 0.49 | | 16.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Esther Rajavelu
CEO | Chief Executive Officer | 47 | 10/01/2025 |
Debra Zack
CTO | Chief Tech/Sci/R&D Officer | 69 | 27/07/2026 |
Timothy Keutzer
COO | Chief Operating Officer | 58 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Milind Deshpande
CHM | Chairman | 69 | 01/01/2014 |
| Director/Board Member | 62 | 01/09/2015 | |
Frank Thomas
CHM | Chairman | 56 | 10/01/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.86% | -0.78% | -39.43% | -16.32% | 69.3M | |
| -0.94% | +0.31% | +40.04% | +103.25% | 69.19B | |
| -0.07% | -3.93% | +32.54% | +75.96% | 62.97B | |
| +3.78% | +2.00% | -12.26% | +387.40% | 27.27B | |
| -0.34% | -5.42% | -3.83% | -16.76% | 24.78B | |
| -0.93% | -1.29% | +25.30% | +16.70% | 25.8B | |
| -1.43% | -1.89% | +21.32% | -17.67% | 20.11B | |
| -4.27% | +2.67% | +219.02% | +362.48% | 18.47B | |
| -1.43% | -1.80% | -8.64% | +537.09% | 14.88B | |
| +0.56% | -0.85% | +51.61% | +163.92% | 14.29B | |
| Average | -0.56% | -0.31% | +32.57% | +159.60% | 30.86B | |
| Weighted average by Cap. | -0.43% | -0.76% | +36.44% | +141.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 47.98M 41.28M 38.87M 35.42M 66.27M 4.57B 66.53M 461M 178M 2.33B 180M 176M 7.37B | 66.8M 57.48M 54.13M 49.32M 92.27M 6.36B 92.64M 641M 248M 3.24B 251M 245M 10.26B |
| Net income | -68.57M -59M -55.55M -50.62M -94.71M -6.52B -95.09M -658M -254M -3.32B -257M -252M -10.53B | 8.57M 7.38M 6.95M 6.33M 11.84M 816M 11.89M 82.32M 31.81M 416M 32.19M 31.49M 1.32B |
| Net Debt | - | - |
Employees
-
| Date | Price | Change |
|---|---|---|
| 10/09/26 | €1.001 | -1.86% |
| 08/09/26 | €1.020 | +0.99% |
| 07/09/26 | €1.010 | -2.42% |
| 04/09/26 | €1.035 | +0.19% |
| 03/09/26 | €1.033 | -1.24% |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.190USD
Average target price
4.000USD
Spread / Average Target
+236.13%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRO Stock
- 2HA Stock
Select your edition
All financial news and data tailored to specific country editions
